Papers/PMID:28151881
Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis.
Medicine2017The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
selenium atom — decreases prostate cancer incidence
Evidence strength: moderate.Findingreplicated ×1“However, the results showed that there was an inverse relationship between serum selenium levels and prostate cancer risk.”
Quoted verbatim from Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis.. - Study
- meta-analysis
- Population
- Participants of 17 observational and trial studies (12 case-control, 4 cohort, 1 RCT) comparing highest versus lowest serum selenium levels
Serum selenium levels and prostate cancer risk: A MOOSE-compliant meta-analysis.2017PMID:2815188110.1097/MD.0000000000005944Permalink